Laboratory-Generated Autologous Skin Substitutes for Burn Treatment in Europe: Narrative Review, Experts’ Opinion, and Legal Considerations
European Burn Journal · 03.06.2025 · 6 (2) · 30
DOI: 10.3390/ebj6020030 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Burn Journal, online erschienen am 03.06.2025. Verfasst von Celine Auxenfans und 25 weiteren Autor:innen. Beteiligte Einrichtung: Banque de Tissus et Cellules, Plateforme de Biotherapies, Hospices Civils de Lyon, 69002 Lyon, France. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss National Science Foundation, COST Action, COST (European Cooperation in Science and Technology).
Abstract (Originalsprache)
Autologous skin substitutes represent a promising advancement in the treatment of burn injuries, offering personalized solutions for patients with extensive skin loss. This white paper synthesizes the current knowledge on laboratory-generated autologous skin substitutes in Europe, incorporating expert opinions and legal considerations. The white paper examines the scientific principles underlying autologous skin substitute development, including cell sourcing, bioengineering techniques, and clinical applications. The regulatory framework governing the production and use of these advanced therapies in Europe is also examined, highlighting challenges in standardization, safety, and approval pathways. The text features expert insights that offer a real-world perspective on the clinical viability and translational hurdles of autologous skin substitutes. The findings highlight the potential of autologous skin substitutes to improve burn treatment outcomes while emphasizing the need for harmonized regulations to facilitate clinical implementation. Despite technological advancements, significant challenges persist, including production costs, scalability, and long-term efficacy. Another focus of this white paper are the legal changes, which have significantly impacted the production and availability of these technologies. The review concludes that while autologous skin substitutes hold great promise, further research, regulatory refinement, and interdisciplinary collaboration are essential to optimize their integration into clinical practice.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Banque de Tissus et Cellules, Plateforme de Biotherapies, Hospices Civils de Lyon, 69002 Lyon, France.
- Pediatric Burn Center, Children's Skin Center, Department of Surgery, University Children's Hospital Zurich, University of Zurich, Lenggstrassse 30, 8008 Zurich, Switzerland.
- Children's Research Center (CRC), University Children's Hospital Zurich, University of Zurich, Lenggstrasse 30, 8008 Zurich, Switzerland.
- Regenerative Therapy Unit, Service of Plastic, Reconstructive & Hand Surgery, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland.
- Tissue Engineering Group, Department of Histology, Instituto de Investigación Biosanitaria ibs.GRANADA, University of Granada, 18012 Granada, Spain.
- Cell Production Center (CPC), Lausanne University Hospital (CHUV), 1005 Lausanne, Switzerland.
ORCID-Profile: Celine Auxenfans, Philippe Abdel-Sayed, Jean-François Brunet, Jesus Chato-Astrain, Gloria Carmona, Anthony de Buys Roessingh, Melinda Farkas, Fredrik Huss, Alexandra Karström, Naiem Moiemen, Vivienne Woodtli, Sophie Böttcher
Förderung
- Swiss National Science Foundation
- COST Action
- COST (European Cooperation in Science and Technology)
- Research Committee of the European Burn Association
- Plan Propio de Investigación y Transferencia de la Universidad de Granada 2023, programa operativo FEDER Andalucía 2021–2027, University of Granada and Conseje…
Zitieren
APA
Auxenfans, C., Valencia, R. G., Abdel-Sayed, P., Alaminos, M., Brunet, J. F., Campos, F., Chato-Astrain, J., Carmona, G., de Buys Roessingh, A., Droz-Georget, S., Farkas, M., Fernandez Gonzalez, A., Gönczi, E., Huss, F., Hartmann, B., Heusi, B., Karström, A., Moiemen, N., Sartoris, G., …, & Böttcher, S. (2025). Laboratory-Generated Autologous Skin Substitutes for Burn Treatment in Europe: Narrative Review, Experts’ Opinion, and Legal Considerations. European Burn Journal, 6(2), 30. https://doi.org/10.3390/ebj6020030
Vancouver
Auxenfans C, Valencia RG, Abdel-Sayed P, Alaminos M, Brunet JF, Campos F, et al. Laboratory-Generated Autologous Skin Substitutes for Burn Treatment in Europe: Narrative Review, Experts’ Opinion, and Legal Considerations. European Burn Journal. 2025;6(2):30. doi:10.3390/ebj6020030
BibTeX
@article{Auxenfans2025,
author = {Auxenfans, Celine and Valencia, Rocio G and Abdel-Sayed, Philippe and Alaminos, Miguel and Brunet, Jean-François and Campos, Fernando and Chato-Astrain, Jesus and Carmona, Gloria and de Buys Roessingh, Anthony and Droz-Georget, Stephanie and Farkas, Melinda and Fernandez Gonzalez, Ana and Gönczi, Enikö and Huss, Fredrik and Hartmann, Bernd and Heusi, Barbara and Karström, Alexandra and Moiemen, Naiem and Sartoris, Giulia and Spranger, Antje and Trouillas, Marina and Rosas, Claudia and Vuola, Jyrki and Woodtli, Vivienne and Schiestl, Clemens and Böttcher, Sophie},
title = {Laboratory-Generated Autologous Skin Substitutes for Burn Treatment in Europe: Narrative Review, Experts’ Opinion, and Legal Considerations},
journal = {European Burn Journal},
year = {2025},
volume = {6},
number = {2},
pages = {30},
doi = {10.3390/ebj6020030}
}
EUVIMED